Inhibition of CD23 processing correlates with inhibition of IL-4- stimulated IgE production in human PBL and hu-PBL-reconstituted SCID mice

Clinical and Experimental Allergy

Volumn 30, Issue 5, 2000, Pages 719-727

  Mayer, R J ^a,b   Bolognese, B J ^a   Al Mahdi, N ^a   Cook, R M ^a   Flamberg, P L ^a   Hansbury, M J ^a   Khandekar, S ^a   Appelbaum, E ^a   Faller, A ^a   Marshall, L A ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

^b SmithKline Beecham Pharmaceutical ^*  (United States)

Author keywords

CD23; IgE; Metalloprotease

Indexed keywords

CD23 ANTIGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E RECEPTOR; INTERLEUKIN 4;

ALLERGIC DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ATOPY; B LYMPHOCYTE; CHO CELL; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IMMUNOGLOBULIN PRODUCTION; IMMUNOMODULATION; MOUSE; NONHUMAN; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SCID MOUSE;

ANIMALS; CHIMERA; ENZYME INHIBITORS; HUMANS; IMMUNOGLOBULIN E; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-4; LYMPHOCYTE TRANSFUSION; LYMPHOCYTES; MATRIX METALLOPROTEINASES; MICE; MICE, SCID; PEPTIDE FRAGMENTS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTORS, IGE; SOLUBILITY;

EID: 0034111468     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.2000.00812.x     Document Type: Article

References (38)

1. 1 Anderson GP, Coyle AJ. TH2 and TH2-like cells in allergy and asthma: pharmacological perspectives. Trends Pharm Sci 1994; 15:324-33.
2. 2 Kay BA. Asthma inflammation. J Allergy Clin Immunol 1991; 87:893-910.
3. 3 Boulet LP, Chapman KR, Cote J et al. Inhibitory effects of an anti-IgE antibody E25 on allergen-induced early asthmatic response. Am J Respir Crit Care Med 1997; 155:1835-40.
4. 4 Fahy JV, Fleming HE, Wong HH et al. The effect of an anti-IgE monoclonal antibody on the early and late phase responses to allergen inhalation in asthmatic subjects. Am J Respir Crit Care Med 1997; 155:1828-34.
5. 5 Sutton BJ, Gould HJ. The human IgE network. Nature 1993; 366:421-8.
6. 6 Vercelli D. Regulation of IgE synthesis in humans. J Biol Regul Hom Agents 1995; 9:1-6.
7. 7 Stavnezer J. Immunoglobulin class switching. Curr Opin Immunol 1996; 8:199-205.
8. 8 Bonnefoy JY, Lecoanet-Henchoz S, Aubry J-P, Gauchet J-F, Graber P. CD23 B-cell activation. Curr Opin Immunol 1995; 7:355-9.
9. 9 Lamers MC, Yu P. Regulation of IgE synthesis. Lessons from the study of IgE transgenic and CD23-deficient mice. Immunol Rev 1995; 148:71-95.
10. 10 Cho S-W, Kilmon MA, Studer EJ, van der Puteen H, Conrad DH. B cell activation and Ig, especially IgE, production is inhibited by high CD23 levels in vivo and in vitro. Cell Immunol 1997; 180:36-46.
11. 11 Liu Y, Cairns JA, Holder MJ et al. Recombinant 25-kDa CD23 and interleukin-1α promote the survival of germinal center B cells: evidence for bifurcation in the development of centro-cytes rescued from apoptosis. Eur J Immunol 1991; 21:1107-14.
12. 12 Bonnefoy JY, Shields J, Mermod JJ. Inhibition of human interleukin 4-induced IgE synthesis by a subset of anti-CD23/Fc∈RII monoclonal antibodies. Eur J Immunol 1990; 20:139-44.
13. 13 Tomita K, Tanigawa T, Yahima H et al. Expression of adhesion molecules on mononuclear cells from individual with stable atopic asthma. Clin Exp Immunol 1997; 27:664-71.
14. 14 Kljaic-Turkalj M, Cvoriscec B, Tudoric N et al. Decrease in CD23+ B lymphocytes and clinical outcome in asthmatic patients receiving specific rush immunotherapy. Int Arch Allergy Immunol 1996; 111:188-94.
15. 15 Marolewski AE, Buckle DR, Christie G et al. CD23 (Fc∈RII) release from cell membranes is mediated by a membrane-bound metalloprotease. Biochem J 1998; 333:573-9.
16. 16 Christie G, Barton A, Bolognese B et al. IgE secretion is attenuated by an inhibitor of proteolytic processing of CD23 (Fc∈RII). Eur J Immunol 1997; 27:3228-35.
17. 17 Harrop JA, McDonnell PC, Brigham-Burke M et al. Herpesvirus entry mediator ligand (HVEM-L), a novel ligand for HVEM/TR2, stimulates proliferation of T cells and inhibits HT29 cell growth. J Biol Chem 1998; 273:27548-56.
18. 18 Hensley P, McDevitt PJ, Brook I et al. The soluble form of E-selectin is an asymmetric monomer. J Biol Chem 1994; 269:23949-58.
19. 19 Letellier M, Nakajima T, Pulido-Cejudo G, Hofstetter H, Delespesse G. Mechanism of formation of human IgE-binding factors (soluble CD23): III. Evidence for a receptor (Fc∈RII) - associated proteolytic activity. J Exp Med 1990; 172:693-700.
20. 20 van der Straten A, Johansen H, Rosenberg M, Sweet R. Introduction and constitutive expression of gene products in cultured Drosophila cells using hygromycin B selection. Curr Meth Mol Biol 1989; 1:1.
21. 21 Angelichio M, Beck J, Johansen H, Ivey-Hoyle M. Comparison of several promoters and polyadenylation signals for use in heterologous gene expression in cultured Drosophila cells. Nuc Acids Res 1991; 19:5037-43.
22. 22 Bickett DM, Green MD, Berman J et al. A high-throughput fluorogenic substrate for interstitial collagenase (MMP-1) and gelatinase (MMP-9). Anal Biochem 1993; 212:58-64.
23. 23 Spiegelberg HL, Beck L, Kocher HP, Fanslow WC, Lucas AH. Role of interleukin-4 in human immunoglobulin E formation in hu-PBL-SCID mice. J Clin Invest 1994; 93:711-7.
24. 24 Reichel M, Nelson BH, Greenberg PD, Rothman PB. The IL-4 receptor alpha-chain cytoplasmic domain is sufficient for activation of JAK-1 and STAT6 and the induction of IL-4 specific gene transcription. J Immunol 1997; 158:5860-7.
25. 25 Walcheck B, Kahn J, Fisher JM et al. Neutrophil rolling altered by inhibition of L-selectin shedding in vitro. Nature 1996; 380:720-3.
26. 26 Bennett TA, Lynam EB, Sklar LA, Rogelj S. Hydroxamate-based metalloproteaseinhibitor blocks shedding of L-selectin adhesion molecule from leukocytes: functional consequences for neutrophil aggregation. J Immunol 1996; 156:3093-7.
27. 27 Gearing AJH, Beckett P, Christodoulou M et al. Processing of tumour necrosis factor-α by metalloproteinases. Nature 1994; 370:555-7.
28. 28 Fujiwara H, Kikutani H, Suematsu S et al. The absence of IgE antibody-mediated augmentation of immune responses in CD23-deficient mice. Proc Natl Acad Sci USA 1996; 91:6835-9.
29. 29 Stief A, Texido G, Sansig G, Eibel H, Le Gros G, van der Putten H. Mice deficient in CD23 reveal its modulatory role in IgE production but no role in T and B cell development. J Immunol 1994; 152:3378-90.
30. 30 Texido G, Eibel H, Le Gros G, van der Putten H. Transgene CD23 expression on lymphoid cells modulates IgE and IgG1 responses. J Immunol 1994; 153:3028-42.
31. 31 Haczku A, Takeda K, Hamelmann E et al. CD23 deficient mice develop allergic airway hyerresponsiveness following sensitization with ovalbumin. Am J Respir Crit Care Med 1997; 156:1945-55.
32. 32 Luo H, Hofstetter H, Banchereau J, Delespesse G. Cross-linking of CD23 antigen by its natural ligand (IgE) or by anti-CD23 antibody prevent B lymphocyte proliferation and differentiation. J Immunol 1991; 146:2122-9.
33. 33 Lee WT, Rao M, Conrad DH. The murine lymphocyte receptor for IgE IV. The mechanism of ligand-specific receptor upregulation on B cells. J Immunol 1987; 139:1191-8.
34. 34 Lecoanet-Henchoz S, Aubry J, Graber P et al. CD23 regulates monocyte activation through a novel interaction with the adhesion molecules CD11b-CD18 and CD11c-CD18. Immunity 1995; 3:119-25.
35. 35 Pochon S, Graber P, Yeager M et al. Demonstration of a second ligand for the low affinity receptor for immunoglobulin E (CD23) using recombinant CD23 reconstituted into fluorescent liposomes. J Exp Med 1992; 176:389-97.
36. 36 Reljic R, Cosentino G, Could HJ. Function of CD23 in the response of human B cells to antigen. Eur J Immunol 1997; 27:572-5.
37. 37 Aubry J, Pochon S, Graber P, Jansen K, Bonnefoy J. CD21 is a ligand for CD23 and regulates IgE production. Nature 1993; 358:505-7.
38. 38 White LJ, Ozanne BW, Graber P, Aubry J-P, Bonnefoy JY, Cushley W. Inhibition of apoptosis in a human pre B-cell line by CD23 is mediated via a novel receptor. Blood 1998; 90:234-43.